[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS4969636A - - Google Patents

Info

Publication number
JPS4969636A
JPS4969636A JP11151172A JP11151172A JPS4969636A JP S4969636 A JPS4969636 A JP S4969636A JP 11151172 A JP11151172 A JP 11151172A JP 11151172 A JP11151172 A JP 11151172A JP S4969636 A JPS4969636 A JP S4969636A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11151172A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP11151172A priority Critical patent/JPS4969636A/ja
Publication of JPS4969636A publication Critical patent/JPS4969636A/ja
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11151172A 1972-11-07 1972-11-07 Pending JPS4969636A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11151172A JPS4969636A (en) 1972-11-07 1972-11-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11151172A JPS4969636A (en) 1972-11-07 1972-11-07

Publications (1)

Publication Number Publication Date
JPS4969636A true JPS4969636A (en) 1974-07-05

Family

ID=14563148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11151172A Pending JPS4969636A (en) 1972-11-07 1972-11-07

Country Status (1)

Country Link
JP (1) JPS4969636A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8038988B2 (en) 2002-02-04 2011-10-18 Allergan, Inc. Method of enhancing hair growth
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9675539B2 (en) 2000-03-31 2017-06-13 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US9750750B2 (en) 2009-11-09 2017-09-05 Allergan, Inc. Compositions and methods for stimulating hair growth
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure
WO2019221641A1 (en) * 2018-05-17 2019-11-21 Общество с ограниченной ответственностью "Гурус БиоФарм" Prostaglandin f2 alpha derivatives for decreasing intraocular pressure

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9675539B2 (en) 2000-03-31 2017-06-13 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8298518B2 (en) 2002-02-04 2012-10-30 Allergan, Inc. Method of enhancing hair growth
US8101161B2 (en) 2002-02-04 2012-01-24 Allergan, Inc. Method of enhancing hair growth
US8263054B2 (en) 2002-02-04 2012-09-11 Allergan, Inc. Method of enhancing hair growth
US10188591B2 (en) 2002-02-04 2019-01-29 Allergan, Inc. Method of enhancing hair growth
US10159631B2 (en) 2002-02-04 2018-12-25 Allergan, Inc. Method of enhancing hair growth
US8926953B2 (en) 2002-02-04 2015-01-06 Allergan, Inc. Method of enhancing hair growth
US8038988B2 (en) 2002-02-04 2011-10-18 Allergan, Inc. Method of enhancing hair growth
US9226931B2 (en) 2002-02-04 2016-01-05 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8986715B2 (en) 2002-02-04 2015-03-24 Allergan, Inc. Method of enhancing hair growth
US8632760B2 (en) 2002-02-04 2014-01-21 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8338479B2 (en) 2005-03-16 2012-12-25 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8299118B2 (en) 2005-03-16 2012-10-30 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8772338B2 (en) 2005-03-16 2014-07-08 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933127B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933120B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8586630B2 (en) 2005-03-16 2013-11-19 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9155716B2 (en) 2005-03-16 2015-10-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8309605B2 (en) 2005-03-16 2012-11-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9750750B2 (en) 2009-11-09 2017-09-05 Allergan, Inc. Compositions and methods for stimulating hair growth
US9763959B2 (en) 2009-11-09 2017-09-19 Allergan, Inc. Compositions and methods for stimulating hair growth
US9849140B2 (en) 2009-11-09 2017-12-26 Allergan, Inc. Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
WO2019221641A1 (en) * 2018-05-17 2019-11-21 Общество с ограниченной ответственностью "Гурус БиоФарм" Prostaglandin f2 alpha derivatives for decreasing intraocular pressure
RU2718744C2 (en) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Prostaglandin f2alpha derivatives for reducing intraocular pressure
US12012375B2 (en) 2018-05-17 2024-06-18 Gurus Biopharm Limited Liability Company Prostaglandin F2 alpha derivatives for decreasing intraocular pressure

Similar Documents

Publication Publication Date Title
JPS4927327A (en)
JPS4969636A (en)
JPS5245060B2 (en)
JPS4950566A (en)
JPS5423523Y2 (en)
JPS5145862B2 (en)
JPS4927402U (en)
JPS499134A (en)
JPS526446Y2 (en)
JPS5215435Y2 (en)
JPS4983776U (en)
JPS499676U (en)
FR2187249A1 (en)
FR2174083A1 (en)
BG18540A1 (en)
CH563133A5 (en)
CH570196A5 (en)
CH570188A5 (en)
BG18063A1 (en)
BG18693A1 (en)
BG17917A1 (en)
BG17897A1 (en)
BG17893A1 (en)
BG17393A1 (en)
CH561397A5 (en)